traffic analytics Rx&D - Canada's Research Based Pharmaceutical Companies
  Rx&DAbout Rx&DPharmaceutical Community
PublicationsMedia CentreStakeholders & PartnershipsMember's Login
 
 
 
  Forgot Password?
  Account Application
Rx&D HomeFrançaisContact Us
Useful LinksSite Map
  Pharmaceutical Community

Code of Conduct - Question & Answers

2. Advertising & Information Dissemination - July 2005

Question 1:
I am working with a member company developing a product information website (for doctors only). In order to inform the healthcare professional that there is a web site for this product we have developed a print “invitation” and a personally addressed letter. The letter has been signed by two specialists (doctors) in the field to inform the recipient that the content has been reviewed by these specialists to help ensure accuracy.

During our review the PAAB reviewer has indicated that this was a contravention of the spirit of the Rx&D code (S. 2.4). It is our feeling that this is a difference of opinion in the interpretation of the code and would like your opinion prior to proceeding.

Response:
The feedback from PAAB is indeed correct, as there is no way to know whether the specialists are signing on behalf of the company. Also note that the material to be used on this site should follow the PAAB guidelines as well.


Revised: September 03, 2005
 
 
Back to top

Home | About Rx&D | Pharmaceutical Community | Publications | Media Centre | Stakeholders & Partnerships
Useful Links | Français | Contact Us | Site Map

55 Metcalfe Street, Suite 1220, Ottawa, Ontario K1P 6L5
Tel.: (613) 236-0455 Reception Fax: (613) 236-6756
Strategic Affairs & Communications Fax: (613) 236-6861
Federal Affairs Fax: (613) 236-7919
© 2007 Rx&D Terms and Conditions of Use
All Rights Reserved